Biotechnology company
Issues related to Medicare and Medicaid coverage and reimbursement; Drug pricing under 340B program and drug pricing issues generally. Issues relating to drug pricing; issues relating to Right to Try. Legislation impacting pharmaceutical development, pricing and reimbursement; Right to Try legislation; Prescription Drug User Fee Act (PDUFA); Drug pricing under 340B program and drug pricing issues generally.
MMM - Medicare/Medicaid MED - Medical/Disease Research/Clinical Labs HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
RIVENDELL GROUP LLP
1440 G Street, NW, Washington, DC, 20005, US
MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch) NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo) MATTHEW BERZOK (LA and Chief Counsel, Rep. Bart Stupak; LA Rep. Peter Deutsch) MATTHEW BERZOK (LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch) NICK KOLOVOS (LA and Counsel, Rep. Anna Eshoo)
LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch LA and Counsel, Rep. Anna Eshoo LA and Chief Counsel, Rep. Bart Stupak; LA Rep. Peter Deutsch LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch LA and Counsel, Rep. Anna Eshoo